Intrahepatic Cholangiocarcinoma Market is driven by Rising Prevalence of Liver Cancer and Advanced Therapeutics
Intrahepatic Cholangiocarcinoma (ICC) treatment encompasses various therapeutic approaches including surgery, chemotherapy, radiation therapy, and targeted molecular therapies for managing bile duct cancer that originates in the liver. The treatment landscape has evolved significantly with the introduction of novel targeted therapies and immunotherapy options, providing better outcomes for...
0 Yorumlar 0 hisse senetleri 215 Views 0 önizleme